11 - 13 October 2023

Landmark Centre, Lagos, Nigeria

Localising clinical insights: Fast and accurate management for West African healthcare




Thursday 8th September | 13:00 - 15:30

Room 1D


How can you localize clinical insights so that your patients get the most benefit from diagnoses and treatments? Join our guest speakers in this workshop for a discussion on cost-effective testing for cervical cancer in developing countries and localizing multiplex syndromic testing.

Talk: Sharing of careHPV experience in Zimbabwe and future projections for the country
: Stephano Gudukeya, Director Social Franchising, PSI Zimbabwe

Talk: Importance of multiplex-syndromic testing in the post pandemic era
Eneko Goya, Director of Infectious Diseases, Molecular Diagnostics GEM EEMEA


Stephano Gudukeya
Director Social Franchising
PSI Zimbabwe

A trained laboratory science and sexual and reproductive health professional, organizational leader, and seasoned program management compliance lead, Mr. Gudukeya brings 21 years of professional experience working in public health in Zimbabwe and Botswana, and 17 years with Population Solutions for Health in Zimbabwe. 
Mr. Gudukeya has a long history of introducing and implementing innovative health solutions. First, as part of a team of experts, Mr. Gudukeya expanded a Franchise of HIV testing facilities, New Start, to become a hub of integrated HIV and SRH service delivery clinics providing HIV testing services, antiretroviral therapy, pre-exposure prophylaxis, TB screening and treatment, Family Planning, cervical cancer prevention, syndromic management of STIs, and services for survivors of SGBV, with an increasing emphasis on programming for the hard-to-reach, such as Key Populations, Adolescent Girls and Young Women and People with Disabilities.
He also led the setting up and accreditation of a molecular laboratory providing HIV Viral load, HPV DNA, and COVID diagnostic services. Mr. Gudukeya worked with a team of nurses and researchers to investigate the feasibility and acceptability of self-sample collection for HPV DNA using QIAGEN’s careHPV platform, the results of which were used to safely introduce self-sample collection in the Cervical Cancer Prevention program.

Eneko Goya
Director of Infectious Diseases
Molecular Diagnostics GEM EEMEA

Eneko Goya had joined QIAGEN on 12th of November 2018 as Associate Director, head of Infectious Diseases  product portfolio for the global emerging countries (APEC, MEA, LATAM) which based in Singapore, bringing more than 14 years experience in Pharma and medical devices industry.
In this role, Eneko is responsible for the development and implementation of QIAGEN Molecular infectious Diseases product line strategy and tactics through specific territory plans and sales teams within Asia Pacific region. He is also involved in the product development process and market segment roadmaps to ensure direct marketability.
He obtained his Bs in Biology and Executive MBA from ESEUNE Business School in Spain.Previously he worked for Curetis GmbH, where he served as the Head of Global Commercial Partners  in charge of Curetis MDx products distribution and BD worldwide. Eneko has worked as Advanced Genomic Solution, in charge of Caris Life Science (Oncology Molecular Tumor Profiling) service in Hong Kong, Singapore and South China.

Note: The session is now over.
If you would like more information or to get in touch with the company, please email us at [email protected].